Hemo Organic Ltd.
Hemo Organic
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹3.95 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 11 08 2021 | Quarterly Results |
| 13 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 24 05 2022 | Audited Results & Quarterly Results |
| 09 08 2022 | Quarterly Results |
| 23 08 2022 | Stock Split |
| 14 11 2022 | Quarterly Results |
| 06 02 2023 | Quarterly Results |
| 26 05 2023 | Audited Results |
| 08 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 28 10 2024 | Quarterly Results |
| 26 12 2024 | Right Issue of Equity Shares & Inter alia, to consider and approve:- 1. Issue of Equity shares of the Company on Rights basis. 2. To transact other businesses as per agenda being circulated. |
| 06 02 2025 | Quarterly Results |
| 20 05 2025 | Quarterly Results & Audited Results |
| 13 08 2025 | Quarterly Results |
| 14 11 2025 | Preferential Issue of shares & Quarterly Results Inter alia, to consider and approve:- 1. To consider and evaluate a proposal for raising funds through the issuance of one or more instruments, including equity shares, warrants convertible into equity shares, or other securities, by way of preferential issue, private placement or any other permissible mode(s), in accordance with the applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws, subject to necessary approvals including approval of the shareholders and other statutory/regulatory authorities, as may be required. 2. To transact other businesses as per agenda being circulated. |
| 11 12 2025 | Preferential Issue of shares & Inter alia, to consider and approve:- 1. Proposal for raising of funds by way of issue of Equity shares and/or Convertible warrants on preferential basis. 2. To fix date, place, and time for conducting Extra-Ordinary General Meeting of the Company for the above-mentioned agenda and to approve the Notice for the EGM. 3. Any other agenda matter to be discussed with the permission of Chairman of the Board Meeting |
| 13 02 2026 | Quarterly Results |
No News data available
